Patent: 9,441,046
✉ Email this page to a colleague
Summary for Patent: 9,441,046
Title: | Methods for increasing forced expiratory volume in asthmatics using benralizumab |
Abstract: | Provided herein is are methods of increasing forced expiratory volume in one second (FEV.sub.1) in an asthma patient, comprising administering to the patient an effective amount of benralizumab or an antigen-binding fragment thereof. |
Inventor(s): | Ward; Christine (Gaithersburg, MD), Roskos; Lorin (Gaithersburg, MD), Wang; Bing (Gaithersburg, MD), Raible; Donald (Berwyn, PA) |
Assignee: | ASTRAZENECA AB (Sodertalje, SE) |
Application Number: | 14/454,138 |
Patent Claims: | see list of patent claims |
Details for Patent 9,441,046
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Astrazeneca Ab | FASENRA | benralizumab | Injection | 761070 | 11/14/2017 | ⤷ Try a Trial | 2033-08-12 |
Astrazeneca Ab | FASENRA | benralizumab | Injection | 761070 | 10/03/2019 | ⤷ Try a Trial | 2033-08-12 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |